BillionToOne is a precision diagnostics company that focuses on genetic testing for disease detection.
BillionToOne's investors include Norwest, 500 Global, Y Combinator, Hummingbird Ventures, HOF Capital.
BillionToOne is headquartered in Menlo Park, United States.
BillionToOne is a precision diagnostics company that focuses on genetic testing for disease detection.
BillionToOne is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BillionToOne — Funding & Investors." VCBacked, June 21, 2024, https://www.vcbacked.co/company/billiontoone. Accessed August 15, 2026.
VCBacked. (2024). BillionToOne — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/billiontoone
{{cite web |title=BillionToOne — Funding & Investors |url=https://www.vcbacked.co/company/billiontoone |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated